Related references
Note: Only part of the references are listed.A review of the herbal phosphodiesterase inhibitors; Future perspective of new drugs
Roja Rahimi et al.
CYTOKINE (2010)
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database
F. Giuliano et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Pharmacotherapy for Erectile Dysfunction
Ian Eardley et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
Christian Gratzke et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Influence of Alcohol on the Hemodynamic Effects and Pharmacokinetic Properties of Mirodenafil: A Single-Dose, Randomized-Sequence, Open-Label, Crossover Study in Healthy Male Volunteers in Korea
Bo-Hyung Kim et al.
CLINICAL THERAPEUTICS (2009)
Clavulanic acid stimulates sexual behaviour in male rats
Johnny S. W. Chan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor
Matthias Loehn et al.
HYPERTENSION (2009)
A new herbal combination, Etana, for enhancing erectile function: an efficacy and safety study in animals
N. Qinna et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2009)
Efficacy and Tolerability of Lodenafil Carbonate for Oral Therapy in Erectile Dysfunction: A Phase II Clinical Trial
Sidney Glina et al.
JOURNAL OF SEXUAL MEDICINE (2009)
2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)
Alan W. Shindel
JOURNAL OF SEXUAL MEDICINE (2009)
2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME)
Alan W. Shindel
JOURNAL OF SEXUAL MEDICINE (2009)
Sexual dysfunction in the older man
M. Albersen et al.
REVIEWS IN CLINICAL GERONTOLOGY (2009)
Molecular Yin and Yang of erectile function and dysfunction
Ching-Shwun Lin et al.
ASIAN JOURNAL OF ANDROLOGY (2008)
Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
Bo-Hyung Kim et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Structure-activity relationships of PDE5 inhibitors
D. Eros et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Clinical applications of centrally acting agents in male sexual dysfunction
W. J. G. Hellstrom
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2008)
Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction
Jae-Seung Paick et al.
JOURNAL OF SEXUAL MEDICINE (2008)
British society for sexual medicine guidelines on the management of erectile dysfunction
Geoff Hackett et al.
JOURNAL OF SEXUAL MEDICINE (2008)
The epidemiology of sexual dysfunctions
Leonard R. DeRogatis et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Salvage of sildenafil failures with bremelanotide: A randomized, double-blind, placebo controlled study
Mohammad Reza Safarinejad et al.
JOURNAL OF UROLOGY (2008)
C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries
Attila Kun et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Preclinical Evidence for the Benefits of Penile Rehabilitation Therapy following Nerve-Sparing Radical Prostatectomy
M. Albersen et al.
ADVANCES IN UROLOGY (2008)
Physiological regulation of penile arteries and veins
D. Prieto
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2008)
Clinical application of CNS-acting agents in FSD
Michael A. Perelman
JOURNAL OF SEXUAL MEDICINE (2007)
Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications
Anthony J. Bella et al.
EUROPEAN UROLOGY (2007)
The future of the oral pharmacotherapy of male erectile dysfunction:: things to come
Stefan Ueckert et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Intracavernous injections of prostaglandin E1 for erectile dysfunction: Patient satisfaction and quality of sex life on long-term treatment
Benjamin Alexandre et al.
JOURNAL OF SEXUAL MEDICINE (2007)
Phosphodiesterase type 5 inhibitors: The day after
Konstantinos Hatzimouratidis et al.
EUROPEAN UROLOGY (2007)
Discovery of 3-methyl-N-(1-oxy-3′,4′,5′,6′-tetrahydro-2′H-[2,4′-bipyridine]-1′-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction
Meena V. Patel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells
Hongxiu Ning et al.
UROLOGY (2006)
Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model
Kwanjin Park et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization
ME Hadley et al.
PEPTIDES (2006)
Predictors and prevalence of erectile dysfunction in a racially diverse population
CS Saigal et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats
WJ Liu et al.
ASIAN JOURNAL OF ANDROLOGY (2005)
Melanocortinergic control of penile erection
H Wessells et al.
PEPTIDES (2005)
Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel
ME Werner et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
A nitric oxide-releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide
JS Kalsi et al.
JOURNAL OF SEXUAL MEDICINE (2005)
A comparative review of the options for treatment of erectile dysfunction - Which treatment for which patient?
K Hatzimouratidis et al.
DRUGS (2005)
Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats
JD Brioni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide
JS Kalsi et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone
R Shabsigh et al.
JOURNAL OF UROLOGY (2004)
A comparative study of sildenafil, NCX-911 and BAY41-2272 on the anococcygeus muscle of diabetic rats
JS Kalsi et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction
TJ Bivalacqua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Melanocortin receptors and erectile function
WJ Martin et al.
EUROPEAN UROLOGY (2004)
3-Thio-quinolinone maxi-K openers for the treatment of erectile dysfunction
KM Boy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice
K Büyükafsar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of rho-kinase and their potential role in the erectile response
K Chitaley et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2003)
Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase β
S Chang et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2003)
A-350619: A novel activator of soluble guanylyl cyclase
LN Miller et al.
LIFE SCIENCES (2003)
YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats
GC Hsieh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue
M Seidler et al.
EUROPEAN UROLOGY (2002)
A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction
S Cellek et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Potassium channels and human corporeal smooth muscle cell tone: Further evidence of the physiological relevance of the Maxi-K channel subtype to the regulation of human corporeal smooth muscle tone in vitro
M Spektor et al.
JOURNAL OF UROLOGY (2002)
Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat
H Mizusawa et al.
JOURNAL OF UROLOGY (2002)
Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1
M Nakane et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction
JD Brioni et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway
K Chitaley et al.
NATURE MEDICINE (2001)
Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine
JPW Heaton
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Drug therapy: Erectile dysfunction.
TF Lue
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Physiological roles and properties of potassium channels in corporal smooth muscle
SW Lee
DRUGS OF TODAY (2000)
Share Paper
